市场活动

查看全部

    Anti-SIRPα antibodies as a potential weapon for cancer immunotherapy via accelerated screening in humanizied mouse models

    December 31, 2019
    Share on:
    Signal regulatory protein a(SIRPa) is a transmembrane peotein with an extracellular region comprising three Ig-like domains and a cytoplasmic region containing immunoreceptor tyrosine-based inhibition motifs which mediate binding of the protein tyrosine phosphatases SHP1 and SHP2. SIRPa is especially abundant in myeloid cells such as macrophages and dendritic cells(DC),whereas it is expressed at very low levels in T,B,and NK,and NK T cells.
    已静音开播,点击恢复音量